Status | Study |
Recruiting |
Study Name: The Effect of Adding Exercise Training to Optimal Therapy in PAH Condition: Pulmonary Arterial Hypertension Date: 2016-11-08 Interventions: Other: Exercise therapy 3-week residential phase and 12-we |
Not yet recruiting |
Study Name: Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients Condition: Pulmonary Arterial Hypertension (PAH) Date: 2016-10-12 Interventions: Drug: QCC374 |
Not yet recruiting |
Study Name: A Study to Find Out Whether the Medicine Macitentan Works in Children With Pulmonary Arterial Hypertension (PAH) Condition: Pulmonary Arterial Hypertension Date: 2016-10-12 Interventions: Drug: Macitentan Dispersible t |
Not yet recruiting |
Study Name: Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients Condition: Pulmonary Arterial Hypertension (PAH) Date: 2016-10-05 Interventions: Drug: QCC374 0.015 mg and 0.06 |
Recruiting |
Study Name: Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2016-09-19 Interventions: Drug: Fulvestrant Fulvestrant 500 mg administered intramuscularly into the buttocks slowly as two 5 mL i |
Recruiting |
Study Name: LenusPro Pump in PAH Treated With Treprostinil Condition: Pulmonary Arterial Hypertension Date: 2016-08-31 |
Recruiting |
Study Name: Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy Condition: Pulmonary Arterial Hypertension Date: 2016-08-26 Interventions: Drug: Adempas (Riociguat, BAY63-2521) |
Withdrawn |
Study Name: Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2016-08-24 Interventions: Drug: Slow Dose Titration Group of Subcutaneous Treprostinil |
Recruiting |
Study Name: [18F]FES PET/CT in PAH Condition: Pulmonary Arterial Hypertension Date: 2016-08-02 Interventions: Drug: [18F] FES [18F] FES PET/CT scan, imaging tracer |
Recruiting |
Study Name: Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension Date: 2016-05-04 Interventions: Drug: Anakinra Other Name: Kineret |